PFIZER LIMITED

Type of Business: Primarily a commercial and distribution entity. While Pfizer, as a global biopharmaceutical company, possesses extensive manufacturing capabilities worldwide, the PFIZER LIMITED entity in Taiwan primarily functions as a trading company, focusing on the import, marketing, sales, and distribution of its pharmaceutical products, vaccines, and healthcare solutions within the Taiwanese market. It is the local subsidiary responsible for commercial operations rather than large-scale primary manufacturing.

Company Introduction:

PFIZER LIMITED in Taiwan is the local subsidiary of Pfizer Inc., one of the world's leading biopharmaceutical companies. Dedicated to applying science and its global resources to improve health and well-being at every stage of life, Pfizer develops and produces medicines and vaccines for a wide range of medical areas. In Taiwan, PFIZER LIMITED plays a crucial role in bringing these innovative therapies and healthcare products to patients. Its operations encompass sales, marketing, distribution, regulatory affairs, medical affairs, and clinical research activities. The company is committed to collaborating with healthcare professionals, government bodies, and patient advocacy groups to address unmet medical needs and enhance healthcare outcomes for the Taiwanese population, ensuring access to Pfizer's global portfolio of pharmaceutical innovations.

PFIZER LIMITED in Taiwan manufactures or sells the following products:

Prevenar 13

Comirnaty

Ibrance

Xalkori

Inlyta

Sutent

Xtandi

Lipitor

Eliquis

Lyrica

Viagra

Caduet

Celebrex

Xeljanz

Vyndaqel

Zithromax

Diflucan